FindTrial
Sign In

A pilot study to compare CAMPATH-1H produced from YO or CHO cells in patients with B-cell chronic lymphocytic leukaemias (Protocol CLL-TF57)

A pilot study to compare CAMPATH-1H produced from YO or CHO cells in patients with B-cell chronic lymphocytic leukaemias (Protocol CLL-TF57)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN59778423
Enrollment
Unknown
Registered
2003-09-12
Start date
2002-07-01
Completion date
Unknown
Last updated
2018-02-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

B-cell chronic lymphocytic leukaemia Cancer Lymphoid leukaemia

Interventions

Randomised controlled trial

Sponsors

Department of Health (UK)
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Haematology patients

Exclusion criteria

Exclusion criteria: Does not meet inclusion criteria

Design outcomes

Primary

MeasureTime frame
Rates of clearance of malignant lymphocytes from peripheral blood with the two antibody preparations to allow direct comparison of the efficacy of both.—

Secondary

MeasureTime frame
Not provided at time of registration—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026